Is Avalo Therapeutics, Inc. (AVTX) a Buy, Sell, or Hold?
NASDAQ : AVTX
Avalo Therapeutics, Inc.
$18.56 USD
$0.01 (0.05%)
- Volume
- 618.04K
- Average Volume
- 1.99M
- Market Capitalization
- $209.62M
- P/E Ratio
- -3.18
- Dividend Yield
- 0.00%
- Price Target
- $46.50
- Year High
- $24.27
- Year Low
- $4.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.66
AVTX vs. The Competition
| Properties | AVTX | AARD | BDTX | CHRS |
|---|---|---|---|---|
| Market Cap | $209.51M | $144.17M | $101.71M | $176.27M |
| Shares Outstanding | $11.29M | $21.88M | $57.3M | $122.41M |
| P/E Ratio | -3.18 | -2.05 | -2.34 | -1.12 |
| EPS | -4.21 | -3.2 | -0.75 | -1.11 |
| Day Low | 18.05 | 6.578 | 1.76 | 1.42 |
| Day high | 18.7 | 6.7 | 1.8 | 1.48 |
| Year Low | 4.81 | 3.35 | 1.6 | 0.81 |
| Year High | 24.27 | 17.94 | 4.94 | 2.616 |
| Average Price 50 | 17.0326 | 4.8486 | 2.2042 | 1.547 |
| Average Price 200 | 16.20087 | 9.102 | 2.76733 | 1.61458 |
| Volume | 618.04K | 4095.07 | 119.74K | 627.74K |
| Average Volume | - | - | - | - |